Other Species / Isoforms
  APS (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K97
TSVTSALKTATYGHs
0 1
APS (human) LADTSALkAAPYGHS K108-ub
APS iso2 (human) LADTSALKAAPYGHS K151
APS (mouse) TSVTSALKTATYGHs K97
APS (rat) TSVTSALKTATYGHS K97
S104-p
KTATYGHsRssEDVS
Upstream
0 1
Treatment
  • LPA
APS (human) kAAPYGHSRssEDVS S115
APS iso2 (human) KAAPYGHSRSSEDVS S158
APS (mouse) KTATYGHsRssEDVS S104-p
APS (rat) KTATYGHSRSSEDVS S104
S106-p
ATYGHsRssEDVSAH
Upstream
0 8
Treatment
  • LPS
APS (human) APYGHSRssEDVSTH S117-p
APS iso2 (human) APYGHSRSSEDVSTH S160
APS (mouse) ATYGHsRssEDVSAH S106-p
APS (rat) ATYGHSRSSEDVSAH S106
S107-p
TYGHsRssEDVSAHA
0 2
APS (human) PYGHSRssEDVSTHA S118-p
APS iso2 (human) PYGHSRSSEDVSTHA S161
APS (mouse) TYGHsRssEDVSAHA S107-p
APS (rat) TYGHSRSSEDVSAHV S107
S125
ARVRKGFSLRNMsLC
0 2
APS (human) ARVRKGFsLRNMsLC S136-p
APS iso2 (human) ARVRKGFSLRNMSLC S179
APS (mouse) ARVRKGFSLRNMsLC S125
APS (rat) ARVRKGFSLRNMSLC S125
S130-p
GFSLRNMsLCVVDGV
0 5
APS (human) GFsLRNMsLCVVDGV S141-p
APS iso2 (human) GFSLRNMSLCVVDGV S184
APS (mouse) GFSLRNMsLCVVDGV S130-p
APS (rat) GFSLRNMSLCVVDGV S130
S145-p
RDLWHRRssPEPDGG
0 2
APS (human) RDMWHRRAsPEPDAA A156
APS iso2 (human) RDMWHRRASPEPDAA A199
APS (mouse) RDLWHRRssPEPDGG S145-p
APS (rat) RDLWHRRASPEPEGG A145
S146-p
DLWHRRssPEPDGGA
0 9
APS (human) DMWHRRAsPEPDAAA S157-p
APS iso2 (human) DMWHRRASPEPDAAA S200
APS (mouse) DLWHRRssPEPDGGA S146-p
APS (rat) DLWHRRASPEPEGGA S146
S303-p
GCVDPGDsEEDTGLS
0 4
APS (human) GCVDPGDsEEDTELS S310-p
APS iso2 (human) GCVDPGDSEEDTELS S353
APS (mouse) GCVDPGDsEEDTGLS S303-p
APS (rat) GCVDPGDSEEDTGLS S303
S325-p
ASRVASCsCELLTDA
0 3
APS (human) ASRVASCSCELLTDA S332
APS iso2 (human) ASRVASCSCELLTDA S375
APS (mouse) ASRVASCsCELLTDA S325-p
APS (rat) ASRVTSCSCELLTEA S325
T342-p
PRPPETTtAVGAVVT
0 1
APS (human) LPRPPETTAVGAVVT T349
APS iso2 (human) LPRPPETTAVGAVVT T392
APS (mouse) PRPPETTtAVGAVVT T342-p
APS (rat) PRPPETMTAVGAVVT T342
S586-p
PLSAHSRsNstEHLL
0 2
APS (human) QLSARSRSNSAERLL S596
APS iso2 (human) QLSARSRSNSAERLL S639
APS (mouse) PLSAHSRsNstEHLL S586-p
APS (rat) PLSARSRSNsTEHLL S586
S588-p
SAHSRsNstEHLLDA
1 2
APS (human) SARSRSNSAERLLEA S598
APS iso2 (human) SARSRSNSAERLLEA S641
APS (mouse) SAHSRsNstEHLLDA S588-p
APS (rat) SARSRSNsTEHLLEA S588-p
T589-p
AHSRsNstEHLLDAA
0 3
APS (human) ARSRSNSAERLLEAV A599
APS iso2 (human) ARSRSNSAERLLEAV A642
APS (mouse) AHSRsNstEHLLDAA T589-p
APS (rat) ARSRSNsTEHLLEAA T589
S597-p
EHLLDAAsGATEEPT
0 1
APS (human) RLLEAVAATAAEEPP A608
APS iso2 (human) RLLEAVAATAAEEPP A651
APS (mouse) EHLLDAAsGATEEPT S597-p
APS (rat) EHLLEAASGATEEPA S597
Y618-p
ARAVENQySFY____
Upstream
2 8
Putative in vivo kinases:
  • INSR (mouse)
Regulatory protein:
  • INSR (mouse)
Treatment
  • insulin
APS (human) ARAVENQySFY____ Y629-p
APS iso2 (human) ARAVENQYSFY____ Y672
APS (mouse) ARAVENQySFY____ Y618-p
APS (rat) ARAVENQySFY____ Y618-p